Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 5,532 shares at $59.83 ($331K) on 2018-02-20, disclosed to the SEC on 2018-02-21.
Scheduled sale ($331k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.82 | 200 | $12K | 3.6% |
| 2 | $59.83 | 1,832 | $110K | 33.1% |
| 3 | $59.84 | 1,100 | $66K | 19.9% |
| 4 | $59.85 | 1,000 | $60K | 18.1% |
| 5 | $59.86 | 900 | $54K | 16.3% |
| 6 | $59.86 | 400 |
| $24K |
| 7.2% |
| 7 | $59.86 | 100 | $6K | 1.8% |
| Total | $59.84 avg | 5,532 | $331K | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |